McKesson Reports Fiscal 2019 Third-Quarter Results
Revenues of $56.2 billion for the third quarter, up 5% year over year.Third-quarter GAAP earnings per diluted share from continuing […]
Revenues of $56.2 billion for the third quarter, up 5% year over year.Third-quarter GAAP earnings per diluted share from continuing […]
SAN FRANCISCO, January 29, 2019—McKesson Corporation is supporting World Cancer Day by expanding its commitment to reduce the devastating impact of cancer by […]
IRVING, Texas, January 28, 2019—Nimesh Jhaveri, MBA, RPh, joins the Health Mart family of community pharmacies as president. With 30 […]
SAN FRANCISCO—January 7, 2019–McKesson Corporation (NYSE:MCK) will release financial results for its third fiscal quarter ended December 31, 2018 on […]
San Francisco & New York—January 7, 2019—McKesson (NYSE:MCK), a leader in healthcare supply chain management solutions and healthcare information technology, […]
CARY, N.C., December 7, 2018 — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, […]
LAS COLINAS, TEXAS and SAN FRANCISCO, December 6, 2018—McKesson Corporation, which has been investing in technologies and services that create […]
ANAHEIM, Calif., December 3, 2018—McKesson will showcase its clinical expertise and comprehensive suite of technology solutions at the American Society […]
SAN FRANCISCO—November 1, 2018–McKesson Corporation (NYSE:MCK) today announced that John H. Hammergren, chairman and chief executive officer (CEO), has decided […]